Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5916-5926

  Liang, Bitao ^a   Workman, Craig ^b   Lee, Janine ^a   Chew, Claude ^a   Dale, Benjamin M ^a   Colonna, Lucrezia ^a   Flores, Marcella ^a   Li, Nianyu ^b   Schweighoffer, Edina ^c   Greenberg, Steven ^a   Tybulewicz, Victor ^c   Vignali, Dario ^b   Clynes, Raphael ^a,d  

^a College of Physicians and Surgeons ^*  (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC GAMMA RECEPTOR GAMMA; FC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN LAG3; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG; ANTIBODY; CD223 ANTIGEN; CD4 ANTIGEN; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN; PTPN6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; DENDRITIC CELL; ENZYME ACTIVATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; CAPPING PHENOMENON; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD4; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC CAPPING; MICE; MICE, KNOCKOUT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, IGG; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 44449110691     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5916     Document Type: Article

References (61)

1. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711. (Pubitemid 37174545)
2. + regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 212: 314-329.
3. + T cells. Immunity 19: 877-889.
4. high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 176: 5293-5298.
5. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212. (Pubitemid 37547898)
6. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
7. Cella, M., C. Dohring, J. Samaridis, M. Dessing, M. Brockhaus, A. Lanzavecchia, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185: 1743-1751. (Pubitemid 27242195)
8. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3: 237-243. (Pubitemid 34218114)
9. Maeda, A., M. Kurosaki, M. Ono, T. Takai, and T. Kurosaki. 1998. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 187: 1355-1360. (Pubitemid 28189125)
10. -/-) mice. Nat. Immunol. 3: 542-548.
11. Liang, S., B. Baibakov, and A. Horuzsko. 2002. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur. J. Immunol. 32: 2418-2426.
12. Huang, C. T., C. J. Workman, D. Flies, X. Pan, A. L. Marson, G. Zhou, E. L. Hipkiss, S. Ravi, J. Kowalski, H. I. Levitsky, et al. 2004. Role of LAG-3 in regulatory T cells. Immunity 21: 503-513. (Pubitemid 39370506)
13. Miyazaki, T., A. Dierich, C. Benoist, and D. Mathis. 1996. Independent modes of natural killing distinguished in mice lacking Lag3. Science 272: 405-408. (Pubitemid 26138176)
14. Workman, C. J., and D. A. Vignali. 2005. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J. Immunol. 174: 688-695. (Pubitemid 40094261)
15. Workman, C. J., L. S. Cauley, I. J. Kim, M. A. Blackman, D. L. Woodland, and D. A. Vignali. 2004. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J. Immunol. 172: 5450-5455. (Pubitemid 38542045)
16. Huard, B., P. Prigent, M. Tournier, D. Bruniquel, and F. Triebel. 1995. CD4/ major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 25: 2718-2721.
17. Hannier, S., M. Tournier, G. Bismuth, and F. Triebel. 1998. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J. Immunol. 161: 4058-4065. (Pubitemid 28468984)
18. + T lymphocytes. Eur. J. Immunol. 24: 3216-3221.
19. Workman, C. J., K. J. Dugger, and D. A. Vignali. 2002. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J. Immunol. 169: 5392-5395. (Pubitemid 35291633)
20. Workman, C. J., and D. A. Vignali. 2003. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur. J. Immunol. 33: 970-979. (Pubitemid 36546685)
21. Niederhuber, J. E., J. A. Frelinger, E. Dugan, A. Coutinho, and D. C. Shreffler. 1975. Effects of anti-Ia serum on mitogenic responses: I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J. Immunol. 115: 1672-1676.
22. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. M. Nadler, and L. H. Glimcher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360: 266-268.
23. St.-Pierre, Y., N. Nabavi, Z. Ghogawala, L. H. Glimcher, and T. H. Watts. 1989. A functional role for signal transduction via the cytoplasmic domains of MHC class II proteins. J. Immunol. 143: 808-812. (Pubitemid 19203802)
24. Scholl, P. R., and R. S. Geha. 1994. MHC class II signaling in B-cell activation. Immunol. Today 15: 418-422. (Pubitemid 24272186)
25. Al-Daccak, R., N. Mooney, and D. Charron. 2004. MHC class II signaling in antigen-presenting cells. Curr. Opin. Immunol. 16: 108-113. (Pubitemid 38198124)
26. Andreae, S., S. Buisson, and F. Triebel. 2003. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102: 2130-2137. (Pubitemid 37122390)
27. Lokshin, A. E., P. Kalinski, R. R. Sassi, R. B. Mailliard, J. Muller-Berghaus, W. J. Storkus, X. Peng, A. M. Marrangoni, R. P. Edwards, and E. Gorelik. 2002. Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. Int. Immunol. 14: 1027-1037.
28. Lang, P., J. C. Stolpa, B. A. Freiberg, F. Crawford, J. Kappler, A. Kupfer, and J. C. Cambier. 2001. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-αβ dimers. Science 291: 1537-1540. (Pubitemid 32179218)
29. Rogers, N. C., E. C. Slack, A. D. Edwards, M. A. Nolte, O. Schulz, E. Schweighoffer, D. L. Williams, S. Gordon, V. L. Tybulewicz, G. D. Brown, and C. Reis e Sousa. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. [Published erratum appears in 2005 Immunity 22: 773-774.] Immunity 22: 507-517.
30. Workman, C. J., D. S. Rice, K. J. Dugger, C. Kurschner, and D. A. Vignali. 2002. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur. J. Immunol. 32: 2255-2263.
31. Vignali, D. A., and J. L. Strominger. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179: 1945-1956. (Pubitemid 24155675)
32. Harbers, S. O., A. Crocker, G. Catalano, V. D'Agati, S. Jung, D. D. Desai, and R. Clynes. 2007. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J. Clin. Invest. 117: 1361-1369. (Pubitemid 46718424)
33. Li, N., Y. Wang, K. Forbes, K. M. Vignali, B. S. Heale, P. Saftig, D. Hartmann, R. A. Black, J. J. Rossi, C. P. Blobel, et al. 2007. Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J. 26: 494-504. (Pubitemid 46160949)
34. Turner, M., P. J. Mee, P. S. Costello, O. Williams, A. A. Price, L. P. Duddy, M. T. Furlong, R. L. Geahlen, and V. L. Tybulewicz. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378: 298-302.
35. Sedlik, C., D. Orbach, P. Veron, E. Schweighoffer, F. Colucci, R. Gamberale, A. Ioan-Facsinay, S. Verbeek, P. Ricciardi-Castagnoli, C. Bonnerot, et al. 2003. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J. Immunol. 170: 846-852. (Pubitemid 36070537)
36. Matsubara, S., T. Koya, K. Takeda, A. Joetham, N. Miyahara, P. Pine, E. S. Masuda, C. H. Swasey, and E. W. Gelfand. 2006. Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation. Am. J. Respir. Cell Mol. Biol. 34: 426-433.
37. Xia, C. Q., R. Peng, F. Beato, and M. J. Clare-Salzler. 2005. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 62: 45-54. (Pubitemid 41025877)
38. Puig-Kroger, A., M. Relloso, O. Fernandez-Capetillo, A. Zubiaga, A. Silva, C. Bernabeu, and A. L. Corbi. 2001. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 98: 2175-2182.
39. Agrawal, S., A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171: 4984-4989. (Pubitemid 37432777)
40. -/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176: 5788-5796.
41. Qian, C., X. Jiang, H. An, Y. Yu, Z. Guo, S. Liu, H. Xu, and X. Cao. 2006. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood 108: 2307-2315. (Pubitemid 44497514)
42. Huby, R. D., R. J. Dearman, and I. Kimber. 1999. Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J. Biol. Chem. 274: 22591-22596. (Pubitemid 129529278)
43. + regulatory T cells. J. Immunol. 178: 4184-4193.
44. Triebel, F. 2003. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol. 24: 619-622. (Pubitemid 37485908)
45. Cappello, P., F. Triebel, M. Iezzi, C. Caorsi, E. Quaglino, P. L. Lollini, A. Amici, E. Di Carlo, P. Musiani, M. Giovarelli, and G. Forni. 2003. LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. Cancer Res. 63: 2518-2525. (Pubitemid 36605192)
46. Li, N., C. J. Workman, S. M. Martin, and D. A. Vignali. 2004. Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223). J. Immunol. 173: 6806-6812. (Pubitemid 39541066)
47. Nakahashi C, S. Tahara-Hanaoka, N. Totsuka, Y. Okoshi, T. Takai, N. Ohkohchi, S. Honda, K. Shibuya, and A. Shibuya. 2006. Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcRγ chain on peritoneal macrophages. J. Immunol. 15: 765-770. (Pubitemid 46095148)
48. Mina-Osorio, P., and E. Ortega. 2004. Signal regulators in FcR-mediated activation of leukocytes? Trends Immunol. 25: 529-535. (Pubitemid 39208351)
49. Wary, K. K., A. Mariotti, C. Zurzolo, and F.G. Giancotti. 1998. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625-634. (Pubitemid 28427581)
50. Pasquier, B., P. Launay, Y. Kanamaru, I. C. Moura, S. Pfirsch, C. Ruffie, D. Henin, M. Benhamou, M. Pretolani, U. Blank, and R. C. Monteiro. 2005. Identification of FcαRI as an inhibitory receptor that controls inflammation: dual role of FcRγ ITAM. Immunity 22: 31-42. (Pubitemid 40143449)
51. Feng, J., M. E. Call, and K. W. Wucherpfennig. 2006. The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site. PLoS Biol. 4: e142. (Pubitemid 43748223)
52. Sato, K., X. L. Yang, T. Yudate, J. S. Chung, J. Wu, K. Luby-Phelps, R. P. Kimberly, D. Underhill, P. D. Cruz, Jr., and K. Ariizumi. 2006. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor γ chain to induce innate immune responses. J. Biol. Chem. 281: 38854-38866. (Pubitemid 46042012)
53. Zheng, Y. M., C. Liu, H. Chen, D. Locke, J. C. Ryan, and M. L. Kahn. 2001. Expression of the platelet receptor GPVI confers signaling via the Fc receptor γ-chain in response to the snake venom convulxin but not to collagen. J. Biol. Chem. 276: 12999-13006. (Pubitemid 37385225)
54. Hamerman, J. A., and L.L. Lanier. 2006. Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006: re1.
55. Takahashi, K., C. D. Rochford, and H. Neumann. 2005. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201: 647-657. (Pubitemid 40289554)
56. Blasius, A. L., M. Cella, J. Maldonado, T. Takai, and M. Colonna. 2006. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107: 2474-2476. (Pubitemid 43345570)
57. Hamerman, J. A., N. K. Tchao, C. A. Lowell, and L. L. Lanier. 2005. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6: 579-586. (Pubitemid 41710728)
58. Hamerman, J. A., J. R. Jarjoura, M. B. Humphrey, M. C. Nakamura, W. E. Seaman, and L. L. Lanier. 2006. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177: 2051-2055. (Pubitemid 44200961)
59. Fuchs, A., M. Cella, T. Kondo, and M. Colonna. 2005. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 106: 2076-2082. (Pubitemid 41291722)
60. Cao, W., D. B. Rosen, T. Ito, L. Bover, M. Bao, G. Watanabe, Z. Yao, L. Zhang, L. L. Lanier, and Y. J. Liu. 2006. Plasmacytoid dendritic cell-specific receptor ILT7-FcεRI γ inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203: 1399-1405. (Pubitemid 43877601)
61. Park-Min, K. H., N. V. Serbina, W. Yang, X. Ma, G. Krystal, B. G. Neel, S. L. Nutt, X. Hu, and L. B. Ivashkiv. 2007. FcγIII-dependent inhibition of interferon-γ responses mediates suppressive effects of intravenous immune globulin. Immunity 26: 67-78. (Pubitemid 46127754)